Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial
    • News

  • Orthocell locks in Singaporean regulatory approval in international commercialisation push for nerve repair product
    • News

    Orthocell locks in Singaporean regulatory approval in international commercialisation push for nerve repair product

    Regenerative medicine business Orthocell (ASX: OCC) has nailed down its first international regulatory approval for the group’s nerve repair product known as Remplir. The formal authorisation from the Health Sciences Authority in Singapore allows the company to begin sales in the nation and builds on its existing markets for the product in Australia and New

    Read More
    Public
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture
    • News

    ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture

    Aspiring financial services provider ARC Funds (ASX:ARC) is set to get a lot more public exposure to new investors having acquired a 30% equity stake in ausbiz Capital, the venture launched by financial media company ausbiz Group – operator of the ausbiz news channel.  This strategic partnership marks a significant development for ARC Funds as

    Read More
    Public
  • Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    • News

    Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise

    One month after making a substantial on-market purchase of shares, accomplished business leader Bruce Dixon has been appointed to the board of Apiam Animal Health (ASX: AHX), an appointment that may draw the attention of both institutional investors and private equity players alike.  Dixon brings over 30 years of leadership experience, most notably as a

    Read More
    Public
  • Income Asset Management flags positive cashflow via strategic platform partnership with Perpetual
    • News

    Income Asset Management flags positive cashflow via strategic platform partnership with Perpetual

    Ambitious fund manager Income Asset Management (ASX: IAM) has flagged the prospect of positive cash flow thanks to a strategic partnership with Perpetual Corporate Trust, which will play a key role in helping IAM improve its underlying business.  Like many smaller financial service businesses, IAM carries high regulatory and operational expenses which meant that even

    Read More
    Public
  • IG data reveals fresh investor confidence following inflation-induced market lull
    • News

    IG data reveals fresh investor confidence following inflation-induced market lull

    New research published from global financial technology company IG reveals positive sentiment from Australian investors following a 2-year pullback in investor confidence, catalysed by cost-of-living pressures that prompted many households to deplete their savings.  IG’s latest survey, the second iteration of A Trader’s Position – reveals traders are optimistic in their outlook about the Australian

    Read More
    Public
  • Elixinol acquires The Healthy Chef and raises capital to seek growth in the wellness products market
    • News

    Elixinol acquires The Healthy Chef and raises capital to seek growth in the wellness products market

    In an attempt to grow their overall wellness business by diversifying their brands, Elixinol Wellness (ASX: EXL) will acquire The Healthy Chef, a premium wellness brand, in a deal expected to accelerate revenue growth and strengthen their position in the clean nutrition sector. The acquisition complements Elixinol’s existing portfolio and marks a significant step towards

    Read More
    Public
  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    • News

    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US

    It’s not often thought about but as we get older, our verbal capabilities deteriorate with age and for some, this can have a drastic impact on their health when unable to communicate the state of their wellbeing. Such issues for those who are non-verbal due to neurodegenerative diseases, however, may soon be solved for those

    Read More
    Public
  • NobleOak acquires RevTech and FiftyUp Club in $11 million deal that ceases life insurance commission payments
    • News

    NobleOak acquires RevTech and FiftyUp Club in $11 million deal that ceases life insurance commission payments

    NobleOak Life (ASX: NOL) has acquired the trailing commissions and FiftyUp Club platform business from RevTech Media Pty Ltd, in a deal valued at $11 million. The acquisition strengthens NobleOak’s position in the Australian life insurance market by granting the Company access to a significant member base and eliminating ongoing commission payments. RevTech, a media

    Read More
    Public
  • Mosaic Brands to shut down five clothing brands and corresponding stores in a bid for survival
    • News

    Mosaic Brands to shut down five clothing brands and corresponding stores in a bid for survival

    Battling to keep the doors open at its flagship Noni B, Katies, Millers and Rivers stores, specialty fashion retail Mosaic Brands (ASX: MOZ) will shutter five of its brands in a drastic move to simplify its business and secure its financial future. All retail and online stores associated with Rockmans, Autograph, Crossroads, W.Lane, and BeMe will

    Read More
    Public
  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use

    It may only be a matter of time until expectant mothers can monitor the heartbeats of their unborn child from home with medtech company HeraMed (ASX: HMD) pursuing regulatory reclassification to enable their HeraBEAT device to be reinstated for commercial distribution.  HeraMED is advancing discussions with the Therapeutic Goods Administration (TGA) to reinstate its HeraBEAT

    Read More
    Public
  • «
  • ‹
  • 17
  • 18
  • 19
  • 20
  • 21
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.